rs115958467

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004278.4(PIGL):​c.424C>A​(p.Leu142Met) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00584 in 1,611,252 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0048 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0060 ( 41 hom. )

Consequence

PIGL
NM_004278.4 missense, splice_region

Scores

1
4
14
Splicing: ADA: 0.0009913
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: 0.182

Publications

8 publications found
Variant links:
Genes affected
PIGL (HGNC:8966): (phosphatidylinositol glycan anchor biosynthesis class L) This gene encodes an enzyme that catalyzes the second step of glycosylphosphatidylinositol (GPI) biosynthesis, which is the de-N-acetylation of N-acetylglucosaminylphosphatidylinositol (GlcNAc-PI). Study of a similar rat enzyme suggests that this protein localizes to the endoplasmic reticulum. [provided by RefSeq, Jul 2008]
PIGL Gene-Disease associations (from GenCC):
  • CHIME syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Orphanet, PanelApp Australia
  • syndromic intellectual disability
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hyperphosphatasia-intellectual disability syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008395642).
BP6
Variant 17-16299976-C-A is Benign according to our data. Variant chr17-16299976-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 159705.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00481 (732/152282) while in subpopulation NFE AF = 0.00745 (507/68016). AF 95% confidence interval is 0.00692. There are 6 homozygotes in GnomAd4. There are 333 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGLNM_004278.4 linkc.424C>A p.Leu142Met missense_variant, splice_region_variant Exon 3 of 7 ENST00000225609.10 NP_004269.1 Q9Y2B2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGLENST00000225609.10 linkc.424C>A p.Leu142Met missense_variant, splice_region_variant Exon 3 of 7 1 NM_004278.4 ENSP00000225609.5 Q9Y2B2-1

Frequencies

GnomAD3 genomes
AF:
0.00481
AC:
732
AN:
152164
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00675
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00188
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00745
Gnomad OTH
AF:
0.00622
GnomAD2 exomes
AF:
0.00509
AC:
1280
AN:
251468
AF XY:
0.00520
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00535
Gnomad ASJ exome
AF:
0.00804
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00152
Gnomad NFE exome
AF:
0.00768
Gnomad OTH exome
AF:
0.00798
GnomAD4 exome
AF:
0.00595
AC:
8681
AN:
1458970
Hom.:
41
Cov.:
28
AF XY:
0.00586
AC XY:
4255
AN XY:
726104
show subpopulations
African (AFR)
AF:
0.000987
AC:
33
AN:
33430
American (AMR)
AF:
0.00575
AC:
257
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00888
AC:
232
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.00133
AC:
115
AN:
86212
European-Finnish (FIN)
AF:
0.00182
AC:
97
AN:
53418
Middle Eastern (MID)
AF:
0.00526
AC:
30
AN:
5706
European-Non Finnish (NFE)
AF:
0.00683
AC:
7581
AN:
1109402
Other (OTH)
AF:
0.00558
AC:
336
AN:
60264
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
360
721
1081
1442
1802
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00481
AC:
732
AN:
152282
Hom.:
6
Cov.:
32
AF XY:
0.00447
AC XY:
333
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41566
American (AMR)
AF:
0.00674
AC:
103
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4828
European-Finnish (FIN)
AF:
0.00188
AC:
20
AN:
10612
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00745
AC:
507
AN:
68016
Other (OTH)
AF:
0.00616
AC:
13
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
43
87
130
174
217
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00671
Hom.:
10
Bravo
AF:
0.00518
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00571
AC:
22
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.00709
AC:
61
ExAC
AF:
0.00498
AC:
604
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00774
EpiControl
AF:
0.00895

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 06, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PIGL: BP4, BS2 -

CHIME syndrome Uncertain:1Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Coloboma, Congenital Heart Disease, Ichthyosiform Dermatosis, Intellectual Disability, and Ear Anomalies (CHIME) Syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Sep 22, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.015
T;T;T;.
Eigen
Benign
0.020
Eigen_PC
Benign
-0.11
FATHMM_MKL
Benign
0.40
N
LIST_S2
Benign
0.21
T;T;T;T
M_CAP
Benign
0.043
D
MetaRNN
Benign
0.0072
T;T;T;T
MetaSVM
Uncertain
-0.24
T
MutationAssessor
Uncertain
2.0
.;.;M;.
PhyloP100
0.18
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.75
.;.;N;N
REVEL
Uncertain
0.48
Sift
Benign
0.089
.;.;T;T
Sift4G
Pathogenic
0.0
D;T;T;T
Polyphen
0.98
.;.;D;.
Vest4
0.39
MVP
0.82
MPC
0.44
ClinPred
0.020
T
GERP RS
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.47
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00099
dbscSNV1_RF
Benign
0.014
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115958467; hg19: chr17-16203290; COSMIC: COSV99848522; API